Lincomycin
FDA Approved: * June 4, 2015Pharm Company: * X-GEN PHARMS INC
Category: Antibiotics
Lincomycin is a lincosamide antibiotic that comes from the actinomycete Streptomyces lincolnensis.[1] A related compound, clindamycin, is derived from lincomycin by using thionyl chloride to replace the 7-hydroxy group with a chlorine atom with inversion of chirality.[2] It was released for medical use in September 1964.[3] Contents 1 Uses 2 Clinical pharmacology 3 Biosynthesis 4 Spectrum of susceptibility 5 See also 6 References Uses Alt... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Lincomycin 300 mg/ml Intramuscular; Intravenous; Subconjunctival Injection, Solution
NDC: 0404-9901
Labeler:
Henry Schein, Inc.
Lincomycin 300 mg/ml Intramuscular; Intravenous; Subconjunctival Injection, Solution
NDC: 25021-193
Labeler:
Sagent Pharmaceuticals
Lincomycin 300 mg/ml Intramuscular; Intravenous; Subconjunctival Injection, Solution
NDC: 39822-0350
Labeler:
X-gen Pharmaceuticals, Inc.
Lincomycin 300 mg/ml Intramuscular; Intravenous; Subconjunctival Injection, Solution
NDC: 39822-0353
Labeler:
X-gen Pharmaceuticals, Inc.
Lincomycin 300 mg/ml Intramuscular; Intravenous Injection, Solution
NDC: 42571-374
Labeler:
Micro Labs Limited
Lincomycin 300 mg/ml Intramuscular; Intravenous; Subconjunctival Injection, Solution
NDC: 50090-4533
Labeler:
A-s Medication Solutions
Lincomycin 300 mg/ml Intramuscular; Intravenous; Subconjunctival Injection, Solution
NDC: 52584-353
Labeler:
General Injectables and Vaccines, Inc.
Lincomycin Hydrochloride 300 mg/ml Intramuscular; Intravenous; Subconjunctival Injection, Solution
NDC: 68083-478
Labeler:
Gland Pharma Limited
Lincomycin Hydrochloride 300 mg/ml Intramuscular; Intravenous; Subconjunctival Injection, Solution
NDC: 68083-479
Labeler:
Gland Pharma Limited
Lincomycin 300 mg/ml Intramuscular; Intravenous Injection, Solution
NDC: 70436-034
Labeler:
Slate Run Pharmaceuticals, LLC
